Disorders of Dental Hard Tissues Induced by Radioiodine-131 (I-131) Therapy Used in Differentiated Thyroid Cancer: An In Vitro Study

被引:3
|
作者
Mester, Alexandru [1 ]
Piciu, Andra [2 ]
Piciu, Doina [3 ]
Petean, Ioan [4 ]
Lucaciu, Patricia Ondine [1 ]
Apostu, Dragos [5 ]
Moisescu-Goia, Cristina [3 ]
Voina-Tonea, Andrada [6 ]
Moldovan, Marioara [7 ]
机构
[1] Univ Med & Pharm Iuliu Hatieganu, Dept Oral Hlth, Cluj Napoca 400012, Romania
[2] Univ Med & Pharm Iuliu Hatieganu, Dept Med Oncol, Cluj Napoca 400012, Romania
[3] Univ Med & Pharm Iuliu Hatieganu, Oncol Inst Ion Chiricuta, Dept Endocrine Tumors & Nucl Med, Cluj Napoca 400012, Romania
[4] Univ Babes Bolyai, Fac Chem & Chem Engn, Cluj Napoca 400294, Romania
[5] Univ Med & Pharm Iuliu Hatieganu, Dept Orthoped, Cluj Napoca 400012, Romania
[6] Univ Med & Pharm Iuliu Hatieganu, Dept Dent Mat, Cluj Napoca 400012, Romania
[7] Univ Babes Bolyai, Inst Chem Raluca Ripan, Dept Polymer Composites, Cluj Napoca 400294, Romania
关键词
oral disease; differentiated thyroid cancer; radioiodine therapy; dental hard tissue; RADIOACTIVE IODINE; ENAMEL; TEETH; MICROHARDNESS;
D O I
10.3390/biomedicines8110475
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aimed to evaluate, in vitro, the effects of I-131 on enamel and dentin in healthy human incisive permanent maxillary teeth. Our in vitro model analogue with the in vivo conditions of differentiated thyroid carcinoma patients treated with I-131, consisted in a solution of I-131 dissolved in artificial saliva. A total of 48 teeth were divided into eight groups (n = 6): control, irradiation groups at 3, 6, 12, 24, 36, 48, and 192 h, respectively. At the end of radiation exposure, radioiodine activity of specimens was assessed. Fine microstructure, nanostructure, surface roughness, and hidroxyapatite (HAP) crystallite diameter were investigated by atomic force microscopy (AFM) to both enamel and dentin structures. There is a constant increase of radioactivity in dental structures at 3, 6, 12, 24 h, due to progressive retention and I-131 migration, with a maximum at 36 h. Enamel showed notable alterations, which was correlated with the increase of the treatment time. A relevant visible distance between the HAP prisms was observed after 24 h. The surface suffered a loss in its compact structure. I-131 acts in the same way on HAP crystallites in dentin as in those in enamel. It was noticed that their morpho-dimensional changes occurred only after 12 h of treatment. Radioiodine-131 determines degradation of enamel and dentin by starting from the alteration of the crystalline network of HAP prisms, transforming them from compact materials into an agglomeration of rocky submicron structures.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [41] Incidence of Radioiodine-induced Gastritis and the Dosage of I-131 Ablation for Differentiated Thyroid Cancer: Results of a Multi-year Analysis
    Intenzo, Charles
    Jabbour, Serge
    Miller, Jeffrey
    Kim, Sung
    Furlong, Kevin
    Ahmed, Intekhab
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [42] HOW SAFE FOR THE PATIENT IS I-131 THERAPY FOR DIFFERENTIATED THYROID-CARCINOMA
    HAYNIE, TP
    VASSILOPOULOUSELLIN, R
    JOURNAL OF NUCLEAR MEDICINE, 1995, 36 (01) : 27 - 28
  • [43] 131I imaging in the therapy of differentiated thyroid cancer
    Vija, L. -M.
    Toubert, M. -E.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2012, 36 (01): : 44 - 51
  • [44] Depression in thyroid cancer patients receiving I-131 therapy
    Sioka, C.
    Giotakos, O.
    Dimakopoulos, N.
    Fourlis, S.
    Zouboulidis, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S292 - S292
  • [45] Parathyroid gland function and bone metabolism after radioiodine ((131)I) therapy for differentiated thyroid cancer -a preliminary study
    Wu, Juqing
    Feng, Huijuan
    Wei, Ouyang
    Chen, Pan
    Wang, Jing
    Deng, Yuying
    Sun Yungang
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [46] RADIOIODINE-131 THERAPY FOR WELL-DIFFERENTIATED THYROID-CANCER - A QUANTITATIVE RADIATION DOSIMETRIC APPROACH - OUTCOME AND VALIDATION IN 85 PATIENTS
    MAXON, HR
    ENGLARO, EE
    THOMAS, SR
    HERTZBERG, VS
    HINNEFELD, JD
    CHEN, LS
    SMITH, H
    CUMMINGS, D
    ADEN, MD
    JOURNAL OF NUCLEAR MEDICINE, 1992, 33 (06) : 1132 - 1136
  • [47] I-123 imaging for the prediction of I-131 therapy for recurrent differentiated thyroid cancer, RDTC, when I-131 tracer is negative but raised thyroglobulin, Tg
    Britton, KE
    Foley, RR
    Siddiqi, A
    Jan, H
    Canizales, A
    Plowman, PN
    Grossman, AB
    Monson, JP
    Besser, GM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1013 - 1013
  • [48] I-131 uptake augmentation by thiazide diuretics in differentiated thyroid cancer patients
    Sayman, HB
    Senmevsim, O
    Kanmaz, B
    Mete, C
    Sager, S
    Onsel, C
    Sonmezoglu, K
    Kabasakal, L
    Uslu, I
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S466 - S466
  • [49] I-131 Avid Tumor Thrombus in a Case of Poorly Differentiated Thyroid Cancer
    Gill, Sana Munir
    Hassan, Aamna
    Bashir, Humayun
    Shafiq, Waqas
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2023, 32 (02) : 178 - 180
  • [50] The first experience with Bexarotene in patients with I-131 negative differentiated thyroid cancer
    Stokkel, M. P. M.
    Smit, J. W.
    Verkooijen, R. B. T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S111 - S111